Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Greenberg Traurig Attorneys Practices Recognized in The Legal 500 Asia Pacific 2025 Edition
-
President Donald Trump's Inaugural California Dance Card Is Blank Says Larry Thompson
-
Convergent Energy and Power Closes $584.5 Million Guaranteed Loan from the U.S. Department of Energy
-
Zach Wilson of Christie's International Real Estate Sereno Brings In Buyer for Record Breaking Sale in Edna Valley, California
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
-
WonderFi Appoints Paul Pathak to Its Board of Directors
-
Exchange Income Corporation to Host Fourth Quarter Results Conference Call on February 27, 2025
-
Optimi Health Provides Corporate Update
-
Athena Bitcoin Global Announces Appointment of Omar Jimenez as Chief Financial Officer
-
American Window Film Announces Acquisition of The Tint Guy's Residential & Commercial Divisions
-
Bank of Montreal Receives Regulatory Approvals for Normal Course Issuer Bid
-
Hydro One To Release Fourth Quarter 2024 Results on February 20, 2025 Before Markets Open
-
XORTX Announces Change of Auditor
-
Granite REIT Declares Distribution for January 2025
-
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
-
MBDA’s Eric Morrissette Launches MBDA’s Innovation Lab to Empower Minority Business Enterprises
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIOA
-
RiverNorth Opportunities Fund, Inc. and RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. Announce Preferred Dividends
-
The Concord Coalition: Deficits and Debt Move Into Uncharted Territory
-
Spark Energy Extends Pegmatite Trend to 28.4km at the Arapaima Lithium Project in Brazil's Lithium Valley
-
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
-
DOJ Files Complaint in Intervention in Baron & Budd Whistleblower Lawsuit Against Walgreens
-
Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and Warrants
-
UT Health San Antonio, UTSA researchers receive prestigious 2025 Hill Prizes for medicine and technology
-
SBA Administrator Guzman Outlines New MySBA Digital Experience Transforming How Business Owners Interact with SBA
-
Meritage Announced 2024 Preliminary Unaudited Results; 2025 Outlook: Accelerating Earning Growth
-
BCT-Bank of Charles Town Reveals Martinsburg Branch Makeover
-
USPHL Announces Non-USA Hockey 18U Youth League
-
Michigan Potash secures conditional commitment for a loan guarantee from the U.S. Department of Energy to enhance food security through major fertilizer project
-
Scott+Scott Attorneys at Law LLP Reminds Investors That It Is Investigating TransMedics Group, Inc. (TMDX)
-
Fortis Inc. to Hold Teleconference and Webcast on February 14 to Discuss 2024 Annual Results
-
Scott+Scott Attorneys at Law LLP Reminds Investors of Its Current Investigation Into ModivCare Inc. (MODV)
-
Hypertec Cloud Partners With Potentia to Power Sustainable AI Cloud Expansion With Additional 480MW of Balanced Capacity Across North America
-
Lawsuit demands HHS Secretary Becerra follow federal law and add COVID vaccine to Vaccine Injury Compensation Program (VICP)
-
GoldMining Announces Change to the Board of Directors
-
Blackboxstocks, Inc. and Evtec Aluminium Limited Mutually Agree to Terminate Share Exchange Agreement
-
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Cleveland-Cliffs to Announce Full-Year and Fourth-Quarter 2024 Earnings Results on February 24 and Host Conference Call on February 25
-
First Industrial Realty Trust Reports Tax Treatment Of Common Stock Distributions
-
Arrowhead Pharmaceuticals Announces Acceptance of New Drug Application by U.S. FDA of Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
-
ProPetro Announces Fourth Quarter 2024 Earnings Call
-
MarketAxess to Host Conference Call Announcing Fourth Quarter and Full-Year 2024 Financial Results on Thursday, February 6, 2025
-
Dime Announces Continued Partnership for the Dime McCarren 5K in 2025
-
Lithium Argentina Shareholders Approve Corporate Migration to Switzerland
-
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Jianzhi Education Technology Group Company Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Moderna Announces Updates on Pandemic Influenza Program
-
Driving Growth and Innovation: Impactful ITServe Alliance Dynamic Year
-
TDG Gold Comments on Freeport-Amarc Gold-Silver-Copper “Aurora” Discovery on Boundary with TDG’s Greater Shasta Project, Tooddoggone

